eltrombopag glenmark 75 mg filmdragerad tablett
glenmark arzneimittel gmbh - eltrombopagolamin - filmdragerad tablett - 75 mg - isomalt hjälpämne; mannitol hjälpämne; eltrombopagolamin 95,7 mg aktiv substans
eltrombopag glenmark 12,5 mg filmdragerad tablett
glenmark arzneimittel gmbh - eltrombopagolamin - filmdragerad tablett - 12,5 mg - isomalt hjälpämne; eltrombopagolamin 15,95 mg aktiv substans; mannitol hjälpämne
eltrombopag glenmark 25 mg filmdragerad tablett
glenmark arzneimittel gmbh - eltrombopagolamin - filmdragerad tablett - 25 mg - eltrombopagolamin 31,9 mg aktiv substans; isomalt hjälpämne; mannitol hjälpämne
eltrombopag glenmark 50 mg filmdragerad tablett
glenmark arzneimittel gmbh - eltrombopagolamin - filmdragerad tablett - 50 mg - mannitol hjälpämne; isomalt hjälpämne; eltrombopagolamin 63,8 mg aktiv substans
eltrombopag zentiva 75 mg filmdragerad tablett
zentiva k.s. - eltrombopagolamin - filmdragerad tablett - 75 mg - isomalt hjälpämne; eltrombopagolamin 95,7 mg aktiv substans; mannitol hjälpämne
eltrombopag zentiva 25 mg filmdragerad tablett
zentiva k.s. - eltrombopagolamin - filmdragerad tablett - 25 mg - eltrombopagolamin 31,9 mg aktiv substans; mannitol hjälpämne; isomalt hjälpämne
eltrombopag zentiva 50 mg filmdragerad tablett
zentiva k.s. - eltrombopagolamin - filmdragerad tablett - 50 mg - isomalt hjälpämne; eltrombopagolamin 63,8 mg aktiv substans; mannitol hjälpämne
revolade
novartis europharm limited - eltrombopag - purpura, trombocytopenisk, idiopatisk - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 och 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 och 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
kadderum 12,5 mg filmdragerad tablett
genepharma s.a. - eltrombopagolamin - filmdragerad tablett - 12,5 mg - polysorbat 80 hjälpämne; mannitol hjälpämne; eltrombopagolamin 15,95 mg aktiv substans
kadderum 50 mg filmdragerad tablett
genepharma s.a. - eltrombopagolamin - filmdragerad tablett - 50 mg - mannitol hjälpämne; eltrombopagolamin 63,8 mg aktiv substans